Changing economic and demographic characteristics are affecting the healthcare needs of patients worldwide. Our healthcare market intelligence services help you to adapt quickly, address demographic shifts and achieve strategic goals at various stages of the product lifecycle – from clinical research and approval to commercialization. We also offer support for developing strategic messaging and positioning of your products by leveraging our deep domain knowledge and marketing communications expertise. Global biotech, pharmaceutical, and medical device companies spread across North America, Europe, and the Asia Pacific, trust us for our ability to provide great insights into specific business challenges both at a local and global level.
We track market trends and competitive activities to help you identify global opportunities and maximize growth. We track competitor products, patents, pricing, distribution channels, and customer segments, and carry out competitive benchmarking to measure how you compare.
We provide go-to-market strategies and facilitate successful product launches by conducting market assessments, competitor landscaping, customer segmentation and decision-making process analysis, distribution supply chain analysis, price-point testing, concept testing, and reimbursement assessments.
We provide IP support to pharma and healthcare companies by conducting patentability searches, providing freedom-to-operate assessments and evaluating in-licensing opportunities.
Netscribes uses a unique combination of primary research expertise and traditional desk research, to provide actionable insights and maximize customer value. With a worldwide presence, fluency in multiple languages, research experience across different regions, Netscribes has the capability to gather and analyze intelligence from anywhere in the world. We have developed specialist panels in various domains and our extensive network helps us to reach out to respondents across the globe.
We utilize multiple data sources to gather market intelligence, which includes:
CATI / CAWI
The global corporate wellness market has been experiencing a robust growth since the last few years. It is currently worth over USD 40 billion and growing at the rate of 16 percent to 17 percent per annum.
Biosimilars are gradually becoming a growing part of the pharmaceutical market and are set to expand over the next decade. According to Netscribes research, by 2022, the global biosimilar market is expected to reach USD 36 billion, while the biologic market is expected to reach USD 261 billion.
3D printing technology has cut a niche for itself in healthcare. 3D printed organ models are commonly used these days to help doctors plan complex surgeries. But that’s just a small part of what 3D printing has to offer in healthcare.